STRATA SKIN SCIENCES, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-02-11: Form 8-K; Period of report 2026-02-09; Description 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 8.01 Other Events; Details 3.01.
- 2025-12-17: Form 8-K; Period of report 2025-12-16; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2025-12-10: Form 8-K; Period of report 2025-12-10; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2025-11-13: Form 8-K; Period of report 2025-11-13; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2026-02-11 | 8-K | 2026-02-09 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 8.01 Other Events | 3.01 As previously disclosed on August 22, 2025, Strata Skin Sciences, Inc. (the “Company”) received a deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. 8.01 The Company anticipates that a Form 25 will be filed with the SEC to deregister its common stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), on or about February 19, 2026. | ef20065511_8k.htm |